Personalized Medicine for ASD
Our approach has expanded to analyze proteomic biomarkers as a way to identify ASD in younger children. Cell-El researchers envision
Our approach has expanded to analyze proteomic biomarkers as a way to identify ASD in younger children. Cell-El researchers envision
We at Cell- El Ltd. are focusing our research on biomarkers in the blood, stool, and urine of children with
Cell-El researchers chose to broaden our biomarker analysis from 2–12 year-olds undergoing Stem Cell Therapy (SCT) to include children and
This article presents the rationale behind stem cell-based treatment for autism patients due to immune and nervous system abnormalities. This
Cell El Ltd. has been studying the effects of stem cell treatment (SCT) on biomarkers in children with ASD ages
Cell-El Ltd’s research, as described previously, focuses on biomarkers of immune dysfunction in ASD that are important to help us
At Cell-El Ltd, we are also taking a high level of interest in Microbiota Transfer Therapy (MTT) – also known
One of the treatments for ASD we at Cell El Ltd look forward to observing and researching is Autologous Mesenchymal
There is a great deal of interest and work being done related to immune dysfunction in individuals with ASD.
As we have been discussing, biomarkers are important to help us understand and treat Autism.